nanotechnology Archives · BioBuzz

NanoBioFAB Works with Defense Health Agency and WVU on Medical Nanosensors

<img width="300" height="292" src="https://b2193782.smushcdn.com/2193782/wp-content/uploads/2021/11/logo-v3-copy-300x292.jpeg?lossy=1&strip=1&webp=1" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image" alt="" decoding="async" srcset="https://b2193782.smushcdn.com/2193782/wp-content/uploads/2021/11/logo-v3-copy.jpeg?size=60x58&lossy=1&strip=1&webp=1 60w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2021/11/logo-v3-copy.jpeg?size=120x117&lossy=1&strip=1&webp=1 120w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2021/11/logo-v3-copy.jpeg?size=180x175&lossy=1&strip=1&webp=1 180w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2021/11/logo-v3-copy.jpeg?size=240x234&lossy=1&strip=1&webp=1 240w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2021/11/logo-v3-copy-300x292.jpeg?lossy=1&strip=1&webp=1 300w" sizes="(max-width: 300px) 100vw, 300px" />

Published on : November 9, 2021November 17, 2021 Published by : Erika Riley

Frederick-based company NanoBioFAB (Nanotechnology and Biotechnology Fabrication), is working with the Defense Health Agency and West Virginia University to improve training for medical and nursing students nationwide. The company, co-founded by Xiaonao Liu and Ruoting Yang, creates small nanosensors that, when added to medical mannequins, can provide feedback to students.

Clene Inc. Enters into Two Leases in Maryland to Materially Expand Manufacturing Capacity of its Lead Asset CNM-Au8®

<img width="300" height="200" src="https://b2193782.smushcdn.com/2193782/wp-content/uploads/2021/05/Clene-300x200.jpg?lossy=1&strip=1&webp=1" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image" alt="" decoding="async" loading="lazy" srcset="https://b2193782.smushcdn.com/2193782/wp-content/uploads/2021/05/Clene.jpg?size=60x40&lossy=1&strip=1&webp=1 60w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2021/05/Clene.jpg?size=120x80&lossy=1&strip=1&webp=1 120w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2021/05/Clene.jpg?size=180x120&lossy=1&strip=1&webp=1 180w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2021/05/Clene.jpg?size=240x160&lossy=1&strip=1&webp=1 240w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2021/05/Clene-300x200.jpg?lossy=1&strip=1&webp=1 300w" sizes="(max-width: 300px) 100vw, 300px" />

Published on : August 11, 2021August 13, 2021 Published by : BioBuzz Media

Clene Inc. (NASDAQ: CLNN) along with its subsidiaries “Clene” and its wholly owned subsidiary Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company dedicated to the treatment of neurodegenerative disease using nanotechnology to treat energetic failure, today announced the completion of two lease agreements that will more than quadruple the company’s manufacturing capacity for its lead asset, CNM-Au8®, a gold nanocrystal suspension.

Abhita Batra, Otomagnetics CEO, Aims to Change the Lives of Childhood Cancer Survivors with Magnetic Drug Delivery Technology

<img width="300" height="300" src="https://b2193782.smushcdn.com/2193782/wp-content/uploads/2018/10/abhita_batra-300x300.png?lossy=1&strip=1&webp=1" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image" alt="" decoding="async" loading="lazy" srcset="https://b2193782.smushcdn.com/2193782/wp-content/uploads/2018/10/abhita_batra-75x75.png?lossy=1&strip=1&webp=1 75w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2018/10/abhita_batra-100x100.png?lossy=1&strip=1&webp=1 100w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2018/10/abhita_batra-150x150.png?lossy=1&strip=1&webp=1 150w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2018/10/abhita_batra.png?size=240x240&lossy=1&strip=1&webp=1 240w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2018/10/abhita_batra-300x300.png?lossy=1&strip=1&webp=1 300w" sizes="(max-width: 300px) 100vw, 300px" />

Published on : October 8, 2018September 20, 2021 Published by : Gina Hagler

Abhita Batra, Otomagnetics CEO, Aims to Change the Lives of Childhood Cancer Survivors with Magnetic Drug Delivery Technology October 8, 2018 Abhita Batra, CEO Otomagnetics, Inc., is leading the growth [….]